Volume 20, Number 7—July 2014
CME ACTIVITY - Synopsis
Lessons for Control of Heroin-Associated Anthrax in Europe from 2009–2010 Outbreak Case Studies, London, UK
Figure 2
![Manifestation of heroin-associated anthrax in patient 1, who injected heroin under the skin of his left buttock 1 week before seeking treatment. Panel A demonstrates severe edema with poorly demarcated erythema. He had debridement within hours of arrival. Panel B demonstrates the extent of debridement required to reach healthy tissue and to reduce the toxin burden; there was copious drainage of fluid and pus as well as bleeding to the area. The tissue between affected and unaffected areas was po](/eid/images/13-1764-F2.jpg)
Figure 2. Manifestation of heroin-associated anthrax in patient 1, who injected heroin under the skin of his left buttock 1 week before seeking treatmentPanel A demonstrates severe edema with poorly demarcated erythemaHe had debridement within hours of arrivalPanel B demonstrates the extent of debridement required to reach healthy tissue and to reduce the toxin burden; there was copious drainage of fluid and pus as well as bleeding to the areaThe tissue between affected and unaffected areas was poorly demarcated.
Page created: June 12, 2014
Page updated: June 12, 2014
Page reviewed: June 12, 2014
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.